{"schema_version":"secwatch.filing_event.v1","accession":"0001438133-23-000066","form_type":"8-K","ticker":"TNDM","cik":"0001438133","company_name":"TANDEM DIABETES CARE INC","filed_at":"2023-05-03T23:59:59+00:00","discovered_at":"2026-05-14T18:03:38.874490+00:00","generated_at":"2026-06-16T00:50:12.358083+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Tandem Diabetes Q1 revenue $186M, up 14% YoY; net loss $(49.1M)","bullets":["Revenue $186.0M (+14% YoY); GAAP net loss $(49.1M) or $(0.75) per share.","Non-GAAP adjusted EBITDA loss $(7.3M) vs $(11.7M) loss a year ago.","Total pump shipments 37,923, up 5% YoY; U.S. sales $148.7M (+19% YoY).","International revenue $37.3M, flat YoY; currency headwinds of $4.0M.","FY 2023 revenue guidance reaffirmed: $790M-$810M; expects gross margin 49-50%."],"urls":{"canonical":"https://secwatch.observer/filing/0001438133-23-000066","json":"https://secwatch.observer/filing/0001438133-23-000066.json","markdown":"https://secwatch.observer/filing/0001438133-23-000066.md","text":"https://secwatch.observer/filing/0001438133-23-000066.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1438133/000143813323000066/0001438133-23-000066-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1438133/000143813323000066/tndm-20230503.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-16T00:50:12.358083+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}